Categories AlphaGraphs, Earnings, Health Care
Earnings Summary: Highlights of Humana’s Q2 2024 report
Humana Inc. (NYSE: HUM), a leading health and well-being company, reported a decrease in adjusted earnings for the second quarter of 2024 when its revenues grew in double digits.
- Second-quarter earnings, on an adjusted basis, dropped to $6.96 per share from $8.94 per share in the prior-year quarter
- Including special items, Q2 net income came in at $5.62 per share, vs. $7.66 per share in the same period last year
- June quarter revenues increased to $29.54 billion from $26.75 billion in the year-ago quarter
- The management revised its FY2024 EPS guidance, on a reported basis, to about $12.81 from the previous forecast of $13.93
- The company affirmed its full-year adjusted earnings guidance at $16.00 per share, and the Insurance segment benefit ratio at around 90%
- As of June 30, 2024, days in claims payable was 41.6 days, which represents a decrease of 0.9 day from March 31, 2024
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
Guardian Pharmacy seeks to raise up to $108 mil in US IPO
Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to go public. In a statement filed with the Securities and
Earnings Preview: Will Micron (MU) maintain recovery momentum in Q4?
After recovering from a rough patch, Micron Technology Inc. (NASDAQ: MU) is preparing to report fourth-quarter results next week, even as the market keeps a close watch on the event
